COVID-19 and Vitamin D: Length of Hospital Stay and Mortality

N/ACompletedNCT05221983

Yuksek Ihtisas University168 enrolled

Overview

The lack of a pharmacological treatment in the COVID-19 pandemic has pushed scientists to search for this issue. Maintaining optimal health is parallel to adequate and balanced nutrition. In this context, can the protective properties of vitamin D play an important role in this pandemic? brought with it the thought. In this study, it was aimed to examine the effect of vitamin D on mortality and hospital stay in COVID-19 disease.

This research was conducted to examine the effect of vitamin D on mortality and hospital stay in COVID-19 disease. For this, the approval of the Ministry of Health and then the ethics committee was obtained. For this reason, patients with positive PCR tests and hospitalized patients with vitamin D levels in their biochemistry were included in the study. The data of the patients were obtained from the medical records. Information such as age, gender, comorbidities, length of hospital stay, vitamin D level were included in the study. According to the statistical analyzes obtained from these data, it has been shown that vitamin D level has no effect on mortality and hospital stay in COVID-19 disease.

Study Type

OBSERVATIONAL

Enrollment

168

Conditions

COVID-19 Pandemic Vitamin D Deficiency

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * COVID-19 PCR (Polymerase Chain Reaction) test positive * Vitamin D level in biochemical parameters * Adult patients hospitalized for COVID-19 Exclusion Criteria: -Patients using drugs that may affect vitamin D absorption, such as corticosteroids, cholesterol-lowering agents, phenobarbital and phenytoin-containing agents

Locations (1)

Republic of Turkey Ministry of Health Ankara City Hospitals Neurology-Orthopedics Hospital

Ankara, Turkey (Türkiye)

Outcomes

Primary Outcomes

Level of Vitamin D

Vitamin D levels of patients with a diagnosis of COVID-10. These results were categorized at the level of deficiency/insufficiency/normal.

Time frame: 1 month later

Relationship between vitamin D level and mortality

Relationship between survival and death by categorized vitamin D level.

Time frame: 1 month later

Relationship between vitamin D level and hospital stay

Length of hospital stay by categorized vitamin D level.

Time frame: 1 month later

Secondary Outcomes

Effects of additional diseases (Diabetes mellitus, hypertension, etc.) on hospital stay and mortality

Evaluation of the impact of comorbidities on survival during COVID-19 disease.

Time frame: 1 month later.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.